CD8A and neoplasm: Moreover, FTY720 treatment revealed that a large part of the effector CD8+ T cells present in the tumor after RT originated from the TdLN, since their frequency in the tumor was significantly reduced upon FTY720 treatment (Figure 3, C and D).